Interstitial florosis and growth factors

Environmental Health Perspectives

Volumn 108, Issue SUPPL. 4, 2000, Pages 751-762

  Lasky, J A ^a   Brody, A R ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Particle inhalation; Peptide growth factors; Platelet derived growth factor; Pulmonary fibrosis; Transforming growth factor beta; Tumor necrosis factor

Indexed keywords

ANTIFIBROTIC AGENT; ASBESTOS FIBER; BERYLLIUM; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; CORTICOSTEROID; CYTOKINE; GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; IRON OXIDE; MESSENGER RNA; MITOGENIC AGENT; PENTOXIFYLLINE; PIRFENIDONE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BB; SILICON DIOXIDE; TITANIUM DIOXIDE; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; GROWTH PROMOTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBRIN FORMATION; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROBLAST; LUNG FIBROSIS; MESENCHYME CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCAR; AIR POLLUTANT; ANIMAL; EXPOSURE; IMMUNOLOGY; INTERSTITIAL LUNG DISEASE; METABOLISM; REVIEW;

ANIMALIA;

AIR POLLUTANTS; ANIMALS; GROWTH SUBSTANCES; HUMANS; INHALATION EXPOSURE; LUNG DISEASES, INTERSTITIAL; PULMONARY FIBROSIS;

EID: 0034242741     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108s4751     Document Type: Article

References (100)

1. The epidemiology of interestitial lung diseases
2. Approach to the understanding, diagnosis, management of interstitial lung disease
3. Surgical Pathology of Non-Neoplastic Lung Disease
4. Cytokine biology and the patrhogenesis of interstsitial lung disease
5. Natural history and treated course of usual and desquamative interstitial pneumonia
6. Survival in idiopathic pulmonary fibrosis (IPF): With histologic correlations in lung biopsies from 100 patients
7. Idiopathic Pulmonary Fibrosis
8. Occupational exposure to metal or wood dust and aeteiology of cryptogenic fibrosing alveolitis
9. The collaborating centers. Cigarette smoking: A risk factor for idiopathic pulmonary fibrosis
10. Inflammation in the pathogenesis of interstitial lung disease
11. Idiopathic pulmonary fibrosis: Pretreatment bronchoalvelolar lavage cellular constituants and their relationship with lung pathology and clinical response to therapy
12. The value of serial bronchoalveolar lavage in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis
13. Physiology of interstitial lung disease
14. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: Results of a prospective, open-label Phase II study
15. Collagens
16. Cytokines of the lung
17. Rapid activation of PDGF-A and -B expression at sites of lung injury in asbestos-exposed rats
18. TNF-alpha receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers
19. Chrysotile asbestos stimulates PDGF-AA production by rat lung fibroblasts in vitro: Evidence for an autocrine loop
20. Chrysotile asbestos upregulates gene expression and production of alpha receptors for platelet-derived growth factor (PDGF-AA) on rat lung fibroblasts
21. Upregulation of the PDGF-alpha-receptor precedes the development of asbestos-induced lung fibrosis in rats
22. Randomized control trial comparing prednisolone alone with cyclophosphamide and low dose presnisolone in combination in cryptogenic fibrosing alveolitis
23. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: A prospective double blind placebo-controlled trial
24. Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group
25. D-Penicillamine prevents collagen accumulation in lungs of rats given bleomycin
26. Cyclosporin as a treatment for intersitital lung disease of unknown aetiology
27. Biology of pulmonary fibrosis
28. An endotoxin-induced serum factor that causes necrosis of tumors
29. Peptide Growth Factors and Their Receptors
30. Cloning of a disintegrin metalloproteinase that processes tumour-necrosis factor-alpha
31. Two tumor necrosis factor receptors: Structure and function
32. Unraveling function in the TNF ligand and receptor families
33. The tumor necrosis factor ligand and receptor families
34. Cytokine biology and the pathogenesis of Interstitial lung disease
35. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice
36. Platelets play an important role in TNF-induced microvascular endothelial cell pathology
37. TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis
38. The role of IL-5 in bleomycin-induced pulmonary fibrosis
39. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury
40. Tumor necrosis factor-Induced expression of platelet-derived growth factor A-chain messenger RNA in fibroblasts
41. Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts
42. Regulation of human lung fibroblast alpha 1(I) procollagen gene expression by tumor necrosis factor alpha, interleukin-1 beta, and prostaglandin E2
43. The transcription of human alpha 1(I) procollagen gene (COL1A1) is suppressed by tumour necrosis factor-alpha through proximal short promoter elements: Evidence for suppression mechanisms mediated by two nuclear-factor binding sites
44. Molecular cloning of genes differentially regulated by TNF-alpha in bovine aortic endothelial cells, fibroblasts and smooth muscle cells
45. Regulation of human lung fibroblast collagen production by recombinant interleukin-1, tumor necrosis factor, and interferon-gamma
46. Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha
47. Tumor necrosis factor stimulates gelatinase and collagenase production by granulation tissue in culture
48. Connective tissue disease
49. Lung cytokine production in bleomycin-induced pulmonary fibrosis
50. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice
51. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis
52. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis
53. Increased susceptibility to silicosis and TNF-alpha production in C57BL/6J mice
54. Reactive oxygen intermediates as regulators of TNF-alpha production in rat lung inflammation induced by silica
55. Persistent overexpression of interleukin-1beta and tumor necrosis factor-alpha in murine silicosis
56. Upregulation of the p75 but not the p55 TNF-alpha receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice
57. Modulation of TNF-alpha secretions by alveolar macrophages and blood monocytes after soot-particle or asbestos fibre exposure
58. TNF alpha and increased chemokine expression in rat lung after particle exposure
59. Progressive lung cell reactions and extracellular matrix production after a brief exposure to asbestos
60. Reduced tumor necrosis factor-alpha and transforming growth factor-beta1 expression in the lungs of inbred mice that fail to develop fibroproliferative lesions consequent to asbestos exposure
61. Increased tumor necrosis factor-alpha (TNF-alpha) gene expression in parainfluenza type 1 (Sendai) virus-induced bronchiolar fibrosis
62. Amiodarone-induced pulmonary toxicity in Fischer rats: Release of tumor necrosis factor alpha and transforming growth factor beta by pulmonary alveolar macrophages
63. Early and persistent alterations in the expression of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor alpha mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation
64. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis
65. Role of tumor necrosis factor-alpha in the spontaneous development of pulmonary fibrosis in viable motheaten mutant mice
66. Molecular pathogenesis of interstitial pneumonitis with TNF-alpha transgenic mice
67. Resistance of TNF/LT alpha double deficient mice to bleomycin-induced fibrosis
68. Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor-beta 1 and myofibroblast accumulation
69. Role of tumor necrosis factor-alpha in regulating fibrotic lung repair
70. Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis
71. Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis
72. Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease
73. Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis. A compartmental analysis
74. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure
75. Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor beta and tumor necrosis factor alpha
76. Tumor necrosis factor alpha gene expression in human monocytic THP-1 cells exposed to beryllium
77. Inhibition of tumor necrosis factor and subsequent endotoxin shock by pirfenidone
78. Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis
79. Antiinflammatory and antifibrotic properties of colchicine: Implications for idiopathic pulmonary fibrosis
80. Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense
81. Exacerbation of murine Pneumocystis carinii infection by adenoviral-mediated gene transfer of a TNF inhibitor
82. Pathobiology of pulmonary fibrosis
83. Contractile cells in normal and fibrotic lung
84. Rat alveolar myofibroblasts acquire alpha smooth muscle actin expression during bleomycin-induced pulmonary fibrosis
85. Fibrotic reactions in the lung: The activation of the lung fibroblast
86. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA
87. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF-loop
88. Regulation of platelet-derived growth factor ligand and receptor gene expression by alpha-thrombin in vascular smooth muscle cells
89. A platelet-derived serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro
90. Peptide Growth Factors and Their Receptors
91. Cell cycle regulation of human diploid fibroblasts: Possible mechanisms of platelet-derived growth factor
92. Two classes of PDGF receptor recognize different isoforms of PDGF
93. Signal transduction by the receptors for platelet-derived growth factor
94. Platelet-derived growth factor (PDGF) receptor alpha-subunit mutant and reconstituted cell lines demonstrate that transforming growth factor-beta can be mitogenic through PDGF A-chain-dependent and -independent pathways
95. Crystal structure of human platelet-derived growth factor BB
96. Platelet-derived growth factor: Morphologic and biochemical studies of binding internalization, and degradation
97. Interleukin-1 enhances the response of osteoblasts to platelet-derived growth factor through the alpha receptor-specific up-regulation
98. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta